EMA seeks input on virtual alternative to animal test

EMA delivers a milestone in the replacement of animals in drug testing with the qualification of a virtual model for repeat-dose toxicity studies.

Merck will assess Quris' AI 'patient-on-a-chip' drug safety ...

German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that aims to identify potential safety problems with new therapeutic can

2nd Gene Therapy Immunogenicity

Modulate, Measure & Predict Immune Response to GTx

Elsevier gets FDA backing for ‘predictive toxicology’ projec...

New Speakers from Roche & Imperial College announced for...

Roche to join ADMET conference this July in London